Can head position and cooling boost brain recovery after cardiac arrest?
NCT ID NCT07769086
First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time
Summary
This trial tests whether specific care strategies used in the intensive care unit after cardiac arrest can improve neurological recovery and survival. Adults who remain comatose after their heartbeat is restored will be cared for using either head elevation or a near-supine position, and either targeted cooling or fever prevention. The study compares these approaches to see which may lead to better brain function and quality of life at 30 and 90 days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Head positioning (head elevation vs. near-supine) and temperature control (targeted hypothermia vs. normothermia/fever prevention) during post-cardiac arrest intensive care
- What this could lead to
- If successful, this could identify simple, low-cost care strategies that improve brain recovery and survival for people who remain comatose after cardiac arrest.
- What could go wrong
- The trial is early and uses hospital-level randomization, so results may be influenced by differences in care quality. The interventions may not improve outcomes and could carry risks like complications from cooling or positioning.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 630 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Master Platform Eligibility: * Adult patients aged 18 years or older * Return of spontaneous circulation after cardiac arrest * Persistent coma after return of spontaneous circulation (GCS motor score \<6) * Requirement for intensive care management Head Positioning Domain Eligibility: * Non-traumatic out-of-hospital or in-hospital cardiac arrest * Systolic blood pressure ≥80 mmHg or mean arterial pressure ≥65 mmHg (fluid resuscitation and vasopressor use permitted; transient hypotension recoverable within 20-30 minutes is acceptable) Temperature Control Domain Eligibility: * Initial non-shockable cardiac arrest rhythm * Systolic blood pressure ≥80 mmHg or mean arterial pressure ≥65 mmHg (fluid resuscitation and vasopressor use permitted; transient hypotension recoverable within 20-30 minutes is acceptable) * Ability to initiate temperature control therapy within 240 minutes after return of spontaneous circulation Exclusion Criteria: Master Platform Exclusion: * Refusal of intensive care management * Extracorporeal cardiopulmonary resuscitation (ECPR) * Pregnancy or possible pregnancy * Cardiac arrest due to intracranial hemorrhage, subarachnoid hemorrhage, cerebral infarction, acute aortic dissection, or terminal cancer (including suspected cases) * Severe chronic obstructive pulmonary disease requiring home oxygen therapy * Poor pre-arrest neurological function (CPC 3-4) or poor overall functional status (OPC 3-4) * Pre-existing do-not-attempt-resuscitation (DNAR) order * Expected early death * Inability to obtain consent from a legally acceptable representative or the participant * Enrollment judged inappropriate by the investigator Head Positioning Domain Exclusion: * Body temperature \<30°C on hospital arrival * Refusal of consent for participation in the head positioning domain * Enrollment judged inappropriate by the investigator * Patients using Impella® (a percutaneous mechanical circulatory support catheter) at the time of ICU admission * Patients using an intra-aortic balloon pump (IABP) at the time of ICU admission * Patients for whom feedback-controlled device-based temperature management or fever prevention is not being performed and is not planned at the time of ICU admission Temperature Control Domain Exclusion: * rCAST \<4.5 * rCAST ≥17.0 * Traumatic cardiac arrest * Body temperature \<30°C on hospital arrival * Refusal of consent for participation in the temperature control domain * Enrollment judged inappropriate by the investigator
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac arrest (CA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
12 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Aso Iizuka Hospital
Iizuka, Fukuoka, 8208505, Japan
-
Chiba Kaihin Municipal Hospital
Chiba, Chiba, 2610012, Japan
-
Hiroshima University Hospital
Hiroshima, Hiroshima, 7348551, Japan
-
Hyogo Emergency Medical Center
Kobe, Hyōgo, 651-0073, Japan
-
Kagawa University Hospital
Kita-gun, Kagawa-ken, 761-0701, Japan
-
Kyoto Katsura Hospital
Kyoto, Kyoto, 6158256, Japan
-
Musashino Red Cross Hospital
Musashino, Tokyo, 1800023, Japan
-
National Hospital Organization Sendai Medical Center
Sendai, Miyagi, 9838520, Japan
-
Nippon medical school hospital
Bunkyō-Ku, Tokyo, 113-8603, Japan
-
Okayama University Hospital
Okayama, Okayama-ken, 7008558, Japan
-
TMG Asaka Medical Center
Asaka, Saitama, 3510023, Japan
-
Tokyo Metropolitan Bokutoh Hospital
Sumida-ku, Tokyo, 1308575, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The heart rhythm threat hiding in heart attack wards
- Hand position in CPR: does comfort compromise compression quality?
- Short CPR practice sessions at work may sharpen hospital resuscitation skills
- Front-Back vs. Front-Side: which defibrillator pad placement saves more lives?
- Spinal fluid and blood may reveal how the brain suffers after cardiac arrest
- Blood tests in the ambulance: a new study probes early brain injury markers